Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases
Arthritis Care & Research2013Vol. 65(9), pp. 1504–1514
Citations Over TimeTop 10% of 2013 papers
Nina Droz, Laurent Gilardin, P. Cacoub, Francis Bérenbaum, Daniel Wendling, Bertrand Godeau, Anne‐Marie Piette, Emmanuelle Dernis, Mikaël Ebbo, Bruno Fautrel, G. Le Guenno, A. Mékinian, Brigitte Bernard‐Chabert, N. Costedoat‐Chalumeau, Élodie Descloux, Jean‐Marie Michot, Sylvie Radenne, Aude Rigolet, Sophie Rivière, J.-L. Yvin, Vincent Thibault, Dominique Thabut, Stanislas Pol, Loı̈c Guillevin, Luc Mouthon, Benjamin Terrier
Abstract
We provide new insights into HBV reactivation in patients receiving treatment for IMIDs. A predefined algorithm may be effective in reducing the risk of HBV reactivation in this population.
Related Papers
- → Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes(2009)142 cited
- → Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro(2012)54 cited
- → Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience(2017)7 cited
- → Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H(2006)24 cited
- → Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series(2019)5 cited